Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| GEPHA | Pharma | 14.2% | 49th pct | 110 |
| Georgia Pharmacy Group | Pharma | 13.5% | 46th pct | 110 |
| Aversi-Pharma | Pharma | 11.2% | 43rd pct | 110 |
| PSP Pharma | Pharma | 6.8% | 30th pct | 110 |
| Impexpharm | Pharma | 6.3% | 26th pct | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Line item | Aversi-Pharma | GEPHA | Georgia Pharmacy Group | PSP Pharma | Impexpharm |
|---|---|---|---|---|---|
| Total Current Assets | 399,099 | 297,560 | 315,396 | 392,371 | 50,341 |
| Total Non-Current Assets | 411,105 | 257,386 | 290,668 | 274,633 | 43,216 |
| TOTAL ASSETS | 810,204 | 554,946 | 606,064 | 667,004 | 93,557 |
| Total Current Liabilities | 224,988 | 238,620 | 303,277 | 248,714 | 14,987 |
| Total Non-Current Liabilities | 75,707 | 114,973 | 218,156 | 94,055 | 18,266 |
| TOTAL LIABILITIES | 300,695 | 353,593 | 521,433 | 342,769 | 33,253 |
| Total Equity | 509,509 | 201,353 | 84,631 | 324,235 | 60,304 |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 83,230 | 170,992 | 327,995 | 112,540 | 18,266 |
| Cash & Equivalents | 32,124 | 8,009 | 19,202 | 20,687 | 3,447 |
| Net Debt | 51,106 | 162,983 | 308,793 | 91,853 | 14,819 |